Literature DB >> 16884311

Probing hot spots at protein-ligand binding sites: a fragment-based approach using biophysical methods.

Alessio Ciulli1, Glyn Williams, Alison G Smith, Tom L Blundell, Chris Abell.   

Abstract

Mapping interactions at protein-ligand binding sites is an important aspect of understanding many biological reactions and a key part of drug design. In this paper, we have used a fragment-based approach to probe "hot spots" at the cofactor-binding site of a model dehydrogenase, Escherichia coli ketopantoate reductase. Our strategy involved the breaking down of NADPH (Kd = 300 nM) into smaller fragments and the biophysical characterization of their binding using WaterLOGSY NMR spectroscopy, isothermal titration calorimetry (ITC), and inhibition studies. The weak binding affinities of fragments were measured by direct ITC titrations under low c value conditions. The 2'-phosphate and the reduced nicotinamide groups were found to contribute a large part of the binding energy. A combination of ITC and site-directed mutagenesis enabled us to locate the fragments at separate hot spots on opposite ends of the cofactor-binding site. This study has identified structural determinants for cofactor recognition that represent a blueprint for future inhibitor design.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16884311     DOI: 10.1021/jm060490r

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  46 in total

1.  Relationship between hot spot residues and ligand binding hot spots in protein-protein interfaces.

Authors:  Brandon S Zerbe; David R Hall; Sandor Vajda; Adrian Whitty; Dima Kozakov
Journal:  J Chem Inf Model       Date:  2012-07-24       Impact factor: 4.956

2.  Identification of Non-nucleoside Human Ribonucleotide Reductase Modulators.

Authors:  Md Faiz Ahmad; Sarah E Huff; John Pink; Intekhab Alam; Andrew Zhang; Kay Perry; Michael E Harris; Tessianna Misko; Suheel K Porwal; Nancy L Oleinick; Masaru Miyagi; Rajesh Viswanathan; Chris Godfrey Dealwis
Journal:  J Med Chem       Date:  2015-12-09       Impact factor: 7.446

3.  Screening a fragment cocktail library using ultrafiltration.

Authors:  Sayaka Shibata; Zhongsheng Zhang; Konstantin V Korotkov; Jaclyn Delarosa; Alberto Napuli; Angela M Kelley; Natasha Mueller; Jennifer Ross; Frank H Zucker; Frederick S Buckner; Ethan A Merritt; Christophe L M J Verlinde; Wesley C Van Voorhis; Wim G J Hol; Erkang Fan
Journal:  Anal Bioanal Chem       Date:  2011-07-13       Impact factor: 4.142

4.  Integrated biophysical approach to fragment screening and validation for fragment-based lead discovery.

Authors:  Hernani Leonardo Silvestre; Thomas L Blundell; Chris Abell; Alessio Ciulli
Journal:  Proc Natl Acad Sci U S A       Date:  2013-07-19       Impact factor: 11.205

5.  The importance of molecular complexity in the design of screening libraries.

Authors:  Shahul H Nilar; Ngai Ling Ma; Thomas H Keller
Journal:  J Comput Aided Mol Des       Date:  2013-09       Impact factor: 3.686

Review 6.  The rise of fragment-based drug discovery.

Authors:  Christopher W Murray; David C Rees
Journal:  Nat Chem       Date:  2009-06       Impact factor: 24.427

Review 7.  Evolutions in fragment-based drug design: the deconstruction-reconstruction approach.

Authors:  Haijun Chen; Xiaobin Zhou; Ailan Wang; Yunquan Zheng; Yu Gao; Jia Zhou
Journal:  Drug Discov Today       Date:  2014-09-27       Impact factor: 7.851

8.  Ligand deconstruction: Why some fragment binding positions are conserved and others are not.

Authors:  Dima Kozakov; David R Hall; Stefan Jehle; Sefan Jehle; Lingqi Luo; Stefan O Ochiana; Elizabeth V Jones; Michael Pollastri; Karen N Allen; Adrian Whitty; Sandor Vajda
Journal:  Proc Natl Acad Sci U S A       Date:  2015-04-27       Impact factor: 11.205

Review 9.  Fragment-based approaches to enzyme inhibition.

Authors:  Alessio Ciulli; Chris Abell
Journal:  Curr Opin Biotechnol       Date:  2007-10-24       Impact factor: 9.740

Review 10.  HTS and hit finding in academia--from chemical genomics to drug discovery.

Authors:  Julie A Frearson; Iain T Collie
Journal:  Drug Discov Today       Date:  2009-09-28       Impact factor: 7.851

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.